View in EDS HTML Full Text PDF Full Text

Efficacy and Safety of Garadacimab in Combination with Standard of Care Treatment in Patients with Severe COVID-19.

Saved in:
Bibliographic Details
Title: Efficacy and Safety of Garadacimab in Combination with Standard of Care Treatment in Patients with Severe COVID-19.
Authors: Papi A; Respiratory Department, University of Ferrara, 44100, Ferrara, Italy. Alberto.papi@unife.it., Stapleton RD; Pulmonary and Critical Care Medicine, University of Vermont, Burlington, VT, USA., Shore PM; Clinical Development, CSL Behring, King of Prussia, USA., Bica MA; Global Clinical Safety and Pharmacovigilance, CSL Behring Innovation, Marburg, Germany., Chen Y; Biostatistics, CSL Behring, King of Prussia, USA., Larbig M; Clinical Development, CSL Behring AG, Bern, Switzerland., Welte T; Department of Pulmonary and Infectious Diseases, Hannover Medical School, Hannover, Germany.
Source: Lung [Lung] 2023 Apr; Vol. 201 (2), pp. 159-170. Date of Electronic Publication: 2023 Mar 31.
Publication Type: Randomized Controlled Trial; Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Springer Verlag Country of Publication: United States NLM ID: 7701875 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-1750 (Electronic) Linking ISSN: 03412040 NLM ISO Abbreviation: Lung Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 37000214
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Efficacy and Safety of Garadacimab in Combination with Standard of Care Treatment in Patients with Severe COVID-19.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Papi+A%22">Papi A</searchLink>; Respiratory Department, University of Ferrara, 44100, Ferrara, Italy. Alberto.papi@unife.it.<br /><searchLink fieldCode="AU" term="%22Stapleton+RD%22">Stapleton RD</searchLink>; Pulmonary and Critical Care Medicine, University of Vermont, Burlington, VT, USA.<br /><searchLink fieldCode="AU" term="%22Shore+PM%22">Shore PM</searchLink>; Clinical Development, CSL Behring, King of Prussia, USA.<br /><searchLink fieldCode="AU" term="%22Bica+MA%22">Bica MA</searchLink>; Global Clinical Safety and Pharmacovigilance, CSL Behring Innovation, Marburg, Germany.<br /><searchLink fieldCode="AU" term="%22Chen+Y%22">Chen Y</searchLink>; Biostatistics, CSL Behring, King of Prussia, USA.<br /><searchLink fieldCode="AU" term="%22Larbig+M%22">Larbig M</searchLink>; Clinical Development, CSL Behring AG, Bern, Switzerland.<br /><searchLink fieldCode="AU" term="%22Welte+T%22">Welte T</searchLink>; Department of Pulmonary and Infectious Diseases, Hannover Medical School, Hannover, Germany.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%227701875%22">Lung</searchLink> [Lung] 2023 Apr; Vol. 201 (2), pp. 159-170. <i>Date of Electronic Publication: </i>2023 Mar 31.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Randomized Controlled Trial; Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer+Verlag%22">Springer Verlag </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>7701875 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1432-1750 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2203412040%22">03412040 </searchLink><i>NLM ISO Abbreviation: </i>Lung <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37000214
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s00408-023-00615-9
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 159
    Titles:
      – TitleFull: Efficacy and Safety of Garadacimab in Combination with Standard of Care Treatment in Patients with Severe COVID-19.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Papi A
      – PersonEntity:
          Name:
            NameFull: Stapleton RD
      – PersonEntity:
          Name:
            NameFull: Shore PM
      – PersonEntity:
          Name:
            NameFull: Bica MA
      – PersonEntity:
          Name:
            NameFull: Chen Y
      – PersonEntity:
          Name:
            NameFull: Larbig M
      – PersonEntity:
          Name:
            NameFull: Welte T
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 04
              Text: 2023 Apr
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 1432-1750
          Numbering:
            – Type: volume
              Value: 201
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: Lung
              Type: main
ResultId 1